Immune response (IgG) following full inoculation with BNT162b2 COVID-19 mRNA among healthcare professionals

Soon after the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in December, 2019, numerous research teams, assisted by vast capital investments, achieved vaccine development in a fraction of time. However, almost 8 months following the initiation of the Europea...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsatsakis, Aristidis, Vakonaki, Elena, Tzatzarakis, Manolis, Flamourakis, Matthaios, Nikolouzakis, Taxiarchis Konstantinos, Poulas, Konstantinos, Papazoglou, Georgios, Hatzidaki, Eleftheria, Papanikolaou, Nikolas C., Drakoulis, Nikolaos, Iliaki, Evangelia, Goulielmos, Georgios N., Kallionakis, Manolis, Lazopoulos, Georgios, Kteniadakis, Stelios, Alegkakis, Athanasios, Farsalinos, Konstantinos, Spandidos, Demetrios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448546/
https://www.ncbi.nlm.nih.gov/pubmed/34515322
http://dx.doi.org/10.3892/ijmm.2021.5033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448546/
https://www.ncbi.nlm.nih.gov/pubmed/34515322
http://dx.doi.org/10.3892/ijmm.2021.5033

Ejemplares similares